Which of the following drugs act by inhibition of AT1 subtype of angiotensin receptors?
**Core Concept**
The AT1 subtype of angiotensin receptors plays a crucial role in the renin-angiotensin-aldosterone system (RAAS), which regulates blood pressure and fluid balance. Inhibition of these receptors leads to vasodilation and decreased aldosterone secretion.
**Why the Correct Answer is Right**
Angiotensin II, a potent vasoconstrictor, acts by binding to AT1 receptors, stimulating vasoconstriction and aldosterone release. Drugs that inhibit the AT1 subtype of angiotensin receptors block this action, leading to decreased blood pressure and reduced aldosterone levels. This class of drugs includes angiotensin receptor blockers (ARBs), which are used to treat hypertension, heart failure, and diabetic nephropathy.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately describe the mechanism of action of the correct answer. While the correct answer inhibits the AT1 subtype of angiotensin receptors, this option does not.
**Option B:** This option is incorrect because it describes a different class of drugs, known as ACE inhibitors, which work by blocking the conversion of angiotensin I to angiotensin II, rather than directly inhibiting the AT1 receptor.
**Option C:** This option is incorrect because it is a different type of antihypertensive medication, known as a calcium channel blocker, which works by inhibiting the influx of calcium ions into vascular smooth muscle cells.
**Clinical Pearl / High-Yield Fact**
ARBs are particularly useful in patients with heart failure, as they can reduce morbidity and mortality by blocking the effects of angiotensin II on the heart.
**Correct Answer:** C. Losartan.